Interestingly, recent data provides evidence that, over time, the initially suppressive T-cell effect mediated by IDO1, changes to a more chronic form of kynurenine pathway activation that leads to MS progression, through production of quinolinic acid by infiltrating macrophages. Here, IDO1 is linked to myeloid sarcoma.